TrialJournal of neuro-oncology2016

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

Yazmin Odia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.